I see spikes
Release time:
2020-08-14
I see peak
Jinxi Pharmaceutical Factory Cao Jiankai
. With the passage of time, peak has gone through 60 years from the small cement factory at the foot of peak mountain. Sixty years is enough to make a city undergo earth-shaking changes, and the peak, after the wind and rain, still stands proudly on the edge of the Wujiang River, becoming a monument in the hearts of the peak.
Last year, I came to Jinxi Pharmaceutical Factory, a big family. Because I have never been in the pharmaceutical industry, everything here makes me very curious. The first time I entered the workshop, I sent photos of me wearing work clothes and sanitary caps to my circle of friends. I was asked by my friends if I was working in the hospital. In fact, entering the workshop is much more complicated than entering the hospital. For example, it is necessary to "go deep" and change into clean clothes of different colors. It is not too much to say that "armed to the teeth"... These initial scenes have remained in my mind until now.
I am engaged in equipment management, and my daily work is to ensure the normal operation of the equipment with two masters. In just over a year, I have witnessed the progress of some equipment from manual to automation, which is our pursuit of efficiency and a higher guarantee of product quality. Of course, the run-in with the new equipment is also a story of love and hate. For example, the new equipment works very well under the debugging of the technicians in the production plant. After they leave, they "lose their temper" from time to time. Sometimes the whole equipment is not well adjusted, which makes us hate and fear. However, these are of course temporary. After we are familiar with their "temper", we will know how to prescribe the right medicine. Every time I solve a good problem and watch the machine run normally, my heart is actually very happy-the peak is making progress, and we are also making progress!
In this more than a year, I also had the honor to witness the "birth" of the suppository line and the cooperation with Kindel. From the confirmation of the production site, the selection of equipment, to the verification of some processes, I went through the process of a production line from idea to birth, and gained a lot. What impressed me more was that when the two sides confirmed the differences in the actual process, they made corrections again and again, and finally successfully completed this step. I think it is precisely because of this rigorous and serious attitude that Jianfeng Pharmaceutical and Germany have more trust and tacit understanding, and bring us more possibilities for cooperation!
The meaning of the beginning is to go on. From the initial birth to the present diversified enterprises, the thorns and thorns all the way explain the persistence of struggle, embody the enterprise spirit of determined to rise to the top and climb the peak bravely. Relying on the strategic policy of "strengthening the main business through cooperation and innovation, standardizing science and seeking development", the peak is gradually strengthening its core competitiveness and moving towards the goal of a century-old enterprise!
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31